Dr. Christopher Brückner joins Dennemeyer & Associates Munich
Dr. Christopher Brückner joins the international IP law firm Dennemeyer & Associates in Munich and brings in his expertise in the areas of chemical, pharmaceutical and biotech matters, as well as European patent and trademark law.
Dr. Robert Fichter, Managing Director at Dennemeyer & Associates, notes: "Many IP experts in the pharmaceutical industry know Dr. Christopher Brückner as the author of the German-English commentary on Supplementary Protection Certificates (SPCs). With his experience as both a patent attorney and a pharmacist, Dr. Brückner is a valuable addition to Dennemeyer and we welcome him to our team!"
Dr. Christopher Brückner studied pharmacy at the Free University of Berlin and was admitted to the German patent bar in 2005. Before joining Dennemeyer, Dr. Brückner worked within the patent department of an internationally-known German company and two patent law firms. A prominent figure in the IP world, his articles are published in law journals, and he is frequently invited to speak on the topic of SPCs at various events. Dr. Brückner is also a co-author of the Singer / Stauder commentary on the European Patent Convention and plans to publish the next issue of the Supplementary Protection Certificates (SPCs) commentary next summer.
Dr. Brückner is a member of VPP, FICPI, EPI, EPLIT, DPhG (German Pharmaceutical Association) and the Richard-Wagner-Verband (Richard Wagner Association).
About this new career path, Dr. Brückner states: "I am excited to be part of the Dennemeyer & Associates team! My entire career has been spent in the pharmaceuticals and IP industry and I look forward to help build up the company’s international SPC practice."
The Higher Regional Court of Dusseldorf has selected Dr. Brückner as a court-appointed expert in 2012 and, in 2016, the Max Planck Institute for Innovation and Competition requested that he participates in the preparation of a study commissioned by the EU.
Dennemeyer & Associates Munich offers the full range of IP services and can serve as a single point of contact in all relevant jurisdictions.
Dennemeyer & Associates is a leading IP law firm with a genuine international span and offices in thirteen European and non-European countries: Australia, Brazil, Croatia, France, Germany, Japan, Luxembourg, Poland, Romania, Russia, South Africa, United Arab Emirates and US. As a pioneer in internationalizing strategic intellectual asset management, Dennemeyer & Associates has specialized in the preparation and worldwide registration of patents, trademarks and designs. We assist our clients in all steps of the prosecution phase of IP management. We have also built up a worldwide network of highly experienced patent and trademark professionals. Our international team of patent and trademark attorneys is admitted to practice before the Patent and Trademark Offices of several additional European and non-European jurisdictions.
The opening of the Unified Patent Court (UPC) on June 1, 2023, raises questions about potential changes to existing licensing regimes.